The importance of the bone marrow microenvironment in multiple myeloma; Differential responses to lithium in vivo

The importance of the bone marrow microenvironment in multiple myeloma; Differential responses to lithium in vivo

Detalles Bibliográficos
Main Authors:	Edwards, C, Mundy, G
Formato:	Conference item
Publicado:	2006

Títulos similares

The Bone Marrow Microenvironment in Multiple Myeloma
por: Edwards, C
Publicado: (2010)

Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.
por: Edwards, C, et al.
Publicado: (2009)

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
por: Edwards, C, et al.
Publicado: (2008)

Decreased bone marrow-derived adiponectin contributes to myeloma pathogenesis in vivo
por: Fowler, J, et al.
Publicado: (2010)

Lithium inhibits the development of myeloma bone disease in vivo.
por: Edwards, C, et al.
Publicado: (2006)

Targeting Wnt signaling in myeloma in vivo; Differential effects on tumor burden and myeloma bone disease
por: Edwards, C, et al.
Publicado: (2007)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Matthew Ho, et al.
Publicado: (2022-11-01)

The ubiquitin-proteasome pathway is dysregulated in myeloma cells in the bone microenvironment in vivo
por: Edwards, C, et al.
Publicado: (2007)

Bone marrow adiposity and multiple myeloma
por: Morris, E, et al.
Publicado: (2018)

Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.
por: Fowler, J, et al.
Publicado: (2012)

The pathogenesis of the bone disease of multiple myeloma.
por: Edwards, C, et al.
Publicado: (2008)

CHARACTERISTICS OF BONE MARROW MICROENVIRONMENT IN MULTIPLE MYELOMA BEFORE AND AFTER TREATMENT
por: V. I. Rugal, et al.
Publicado: (2019-03-01)

Editorial: The role of the bone marrow microenvironment in multiple myeloma evolution and therapy
por: Carolina Schinke, et al.
Publicado: (2023-02-01)

Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment
por: Alessandro Natoni, et al.
Publicado: (2019-10-01)

In vivo bone marrow microenvironment siRNA delivery using lipid–polymer nanoparticles for multiple myeloma therapy
por: Guimarães, Pedro PG, et al.
Publicado: (2024)

Host Bone Marrow-Derived Stromal Cells Promote Myeloma Initiation and Development of Osteolysis
por: Fowler, J, et al.
Publicado: (2008)

Osteoclasts in Myeloma Are Derived from Gr-1(+)CD11b(+) Myeloid Immune Suppressor Cells of the Bone Marrow Niche in Vivo
por: Zhuang, J, et al.
Publicado: (2008)

Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment
por: Raquel Lopes, et al.
Publicado: (2022-07-01)

Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells
por: Kuntal Bhowmick, et al.
Publicado: (2024-06-01)

Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment
por: Daniela Belloni, et al.
Publicado: (2018-04-01)

Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma
por: Chunmei Kuang, et al.
Publicado: (2023-04-01)

Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma
por: Morris, E, et al.
Publicado: (2018)

Bone marrow adipocytes and multiple myeloma
por: A. A. Philchenkov
Publicado: (2019-04-01)

Osteoclasts in myeloma are derived from Gr-1+CD11b+mononuclear cells of the bone marrow niche
por: Zhuang, J, et al.
Publicado: (2007)

Myeloma cells decrease EphB4 expression in osteoblasts; A novel mechanism for regulation of bone formation in multiple myeloma
por: Bates, A, et al.
Publicado: (2007)

Myeloma cells decrease EphB4 expression in osteoblasts: A novel mechanism for regulation of bone formation in multiple myeloma
por: Bates, A, et al.
Publicado: (2007)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
por: A. S. Khudovekova, et al.
Publicado: (2021-09-01)

Autophagy and the Bone Marrow Microenvironment: A Review of Protective Factors in the Development and Maintenance of Multiple Myeloma
por: Kamron R. Hamedi, et al.
Publicado: (2022-05-01)

#38. Cholesterol increases bone marrow tumour burden in myeloma in vivo and promotes myeloma cell viability and bortezomib resistance ex vivo
por: B. Gámez, et al.
Publicado: (2024-04-01)

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.
por: Locklin, R, et al.
Publicado: (2007)

The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease.
por: Julia Dotterweich, et al.
Publicado: (2016-01-01)

Bone marrow adipocytes is a new player in supporting myeloma cells proliferation and survival in myeloma microenvironment
por: Xiaoqian Wei, et al.
Publicado: (2024-02-01)

A murine model of myeloma that allows genetic manipulation of the host microenvironment.
por: Fowler, J, et al.
Publicado: (2009)

Increasing adiponectin via an apolipoprotein peptide mimetic, L-4F, increases bone formation in normal mice and prevents myeloma bone disease in vivo
por: Fowler, J, et al.
Publicado: (2011)

Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way
por: Domenica Giannandrea, et al.
Publicado: (2022-03-01)

Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment
por: Lanting Liu, et al.
Publicado: (2020-11-01)

The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
por: Gámez, B, et al.
Publicado: (2021)

PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients
por: Federica Costa, et al.
Publicado: (2021-01-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
por: D Santosa, et al.
Publicado: (2020-12-01)

The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
por: Beatriz Gámez, et al.
Publicado: (2022-01-01)